Reneo Pharmaceuticals Buy Hold or Sell Recommendation
| RPHMDelisted Stock | USD 18.20 1.40 8.33% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Reneo Pharmaceuticals is 'Not Rated'. The recommendation algorithm takes into account all of Reneo Pharmaceuticals' available fundamental, technical, and predictive indicators you will find on this site.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. Note, we conduct extensive research on individual companies such as Reneo and provide practical buy, sell, or hold advice based on investors' constraints. Reneo Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.
Reneo |
Execute Reneo Pharmaceuticals Buy or Sell Advice
The Reneo recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Reneo Pharmaceuticals. Macroaxis does not own or have any residual interests in Reneo Pharmaceuticals or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Reneo Pharmaceuticals' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Not Rated
Reneo Pharmaceuticals Trading Alerts and Improvement Suggestions
| Reneo Pharmaceuticals is now traded under the symbol OKUR. Please update your portfolios or report it if you believe this is an error. Report It! | |
| Reneo Pharmaceuticals is not yet fully synchronised with the market data | |
| Reneo Pharmaceuticals appears to be risky and price may revert if volatility continues | |
| Reneo Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| Reneo Pharmaceuticalshas 3,398,311 shares shorted by Reneo Pharmaceuticals investors is about 100% of outstending shares | |
| Net Loss for the year was (77.39 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Reneo Pharmaceuticals currently holds about 126.85 M in cash with (63.68 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.18. | |
| Over 88.0% of the company shares are owned by institutional investors |
Reneo Pharmaceuticals Returns Distribution Density
The distribution of Reneo Pharmaceuticals' historical returns is an attempt to chart the uncertainty of Reneo Pharmaceuticals' future price movements. The chart of the probability distribution of Reneo Pharmaceuticals daily returns describes the distribution of returns around its average expected value. We use Reneo Pharmaceuticals price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Reneo Pharmaceuticals returns is essential to provide solid investment advice for Reneo Pharmaceuticals.
| Mean Return | 0.34 | Value At Risk | -4.88 | Potential Upside | 6.12 | Standard Deviation | 3.27 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Reneo Pharmaceuticals historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Note: Acquisition by Leonard Braden Michael of 68746 shares of Reneo Pharmaceuticals at 1.4964 subject to Rule 16b-3 [view details]
Reneo Pharmaceuticals Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Reneo . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Reneo Pharmaceuticals Buy or Sell Advice
When is the right time to buy or sell Reneo Pharmaceuticals? Buying financial instruments such as Reneo Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Reneo Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Exotic Funds Thematic Idea Now
Exotic Funds
Funds or Etfs with high minimum investment requirement that manage portfolios of alternative investments such as hedge funds, options, futures, real estate or commodities. The Exotic Funds theme has 43 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Exotic Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Other Consideration for investing in Reneo Stock
If you are still planning to invest in Reneo Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Reneo Pharmaceuticals' history and understand the potential risks before investing.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |